Stay updated on Rituximab in Eosinophilic Granulomatosis Clinical Trial
Sign up to get notified when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.

Latest updates to the Rituximab in Eosinophilic Granulomatosis Clinical Trial page
- Check4 days agoChange DetectedThe page now includes a new line stating 'No longer looking for participants', indicating that recruitment for the study has ended. This informs readers that enrollment is closed and no new participants can join.SummaryDifference0.4%

- Check11 days agoChange DetectedThe page's revision label was updated from v3.5.4 to v3.5.5, signaling a minor update to the study record page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page’s revision label changed from v3.5.3 to v3.5.4, signaling a minor update to the page. There is no evident modification to the study details, eligibility criteria, or results in the provided context.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision label updated from v3.5.2 to v3.5.3 on the page. This reflects a minor deployment or content refresh to the study details page.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision: v3.5.2 is now displayed, replacing the previous v3.5.0.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Rituximab in Eosinophilic Granulomatosis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rituximab in Eosinophilic Granulomatosis Clinical Trial page.